Alliancebernstein L.P. Cv Rx, Inc. Transaction History
Alliancebernstein L.P.
- $287 Billion
- Q3 2024
A detailed history of Alliancebernstein L.P. transactions in Cv Rx, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 20,670 shares of CVRX stock, worth $276,564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,670
Previous 20,670
-0.0%
Holding current value
$276,564
Previous $247,000
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CVRX
# of Institutions
86Shares Held
14.4MCall Options Held
56.3KPut Options Held
41.8K-
Johnson & Johnson New Brunswick, NJ4.1MShares$54.9 Million11.52% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$31.7 Million1.6% of portfolio
-
Black Rock Inc. New York, NY876KShares$11.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$11 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT683KShares$9.14 Million0.85% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $275M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...